TyG-VLR

1. TyG-VLR raises the risk of stroke in humans (HR 1.21, 95% CI 1.12-1.31).

   Humansin participants with CKM stages 0-3n = 7,132

   Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis

   Cardiovascular diabetology·25 Jul 2026

More on Stroke

1. TyG-VLR raises the risk of heart disease in humans (HR 1.11, 95% CI 1.05-1.18).

   Humansin participants with CKM stages 0-3n = 7,132

   Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis

   Cardiovascular diabetology·25 Jul 2026

More on Heart disease

1. TyG-VLR raises the risk of cardiovascular disease in humans (HR 1.15, 95% CI 1.10-1.21).

   Humansin participants with CKM stages 0-3n = 7,132

   Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis

   Cardiovascular diabetology·25 Jul 2026

More on Cardiovascular disease